Examining the profile of high-potency cannabis and its association with severity of cannabis dependence
Authors:
Top Cited Papers
Open Access
- 27 July 2015
- journal article
- research article
- Published by Cambridge University Press (CUP) in Psychological Medicine
- Vol. 45 (15) , 3181-3189
Abstract
Background: Cannabis use is decreasing in England and Wales, while demand for cannabis treatment in addiction services continues to rise. This could be partly due to an increased availability of high-potency cannabis.Method: Adults residing in the UK were questioned about their drug use, including three types of cannabis (high potency: skunk; low potency: other grass, resin). Cannabis types were profiled and examined for possible associations between frequency of use and (i) cannabis dependence, (ii) cannabis-related concerns.Results: Frequent use of high-potency cannabis predicted a greater severity of dependence [days of skunk use per month: b = 0.254, 95% confidence interval (CI) 0.161–0.357, p < 0.001] and this effect became stronger as age decreased (b = −0.006, 95% CI −0.010 to −0.002, p = 0.004). By contrast, use of low-potency cannabis was not associated with dependence (days of other grass use per month: b = 0.020, 95% CI −0.029 to 0.070, p = 0.436; days of resin use per month: b = 0.025, 95% CI −0.019 to 0.067, p = 0.245). Frequency of cannabis use (all types) did not predict severity of cannabis-related concerns. High-potency cannabis was clearly distinct from low-potency varieties by its marked effects on memory and paranoia. It also produced the best high, was preferred, and most available.Conclusions: High-potency cannabis use is associated with an increased severity of dependence, especially in young people. Its profile is strongly defined by negative effects (memory, paranoia), but also positive characteristics (best high, preferred type), which may be important when considering clinical or public health interventions focusing on cannabis potency.Keywords
This publication has 30 references indexed in Scilit:
- Cannabidiol for the treatment of cannabis withdrawal syndrome: a case reportJournal of Clinical Pharmacy and Therapeutics, 2012
- Sub-chronic impact of cannabinoids in street cannabis on cognition, psychotic-like symptoms and psychological well-beingPsychological Medicine, 2011
- Taming THC: potential cannabis synergy and phytocannabinoid‐terpenoid entourage effectsBritish Journal of Pharmacology, 2011
- Mephedrone, new kid for the chop?Addiction, 2010
- Cannabidiol Attenuates the Appetitive Effects of Δ9-Tetrahydrocannabinol in Humans Smoking Their Chosen CannabisNeuropsychopharmacology, 2010
- High-potency cannabis and the risk of psychosisThe British Journal of Psychiatry, 2009
- Attentional bias in addictive behaviors: A review of its development, causes, and consequencesDrug and Alcohol Dependence, 2008
- Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabisThe British Journal of Psychiatry, 2008
- Potency of Δ9–THC and Other Cannabinoids in Cannabis in England in 2005: Implications for Psychoactivity and Pharmacology*Journal of Forensic Sciences, 2008
- Strong increase in total delta-THC in cannabis preparations sold in Dutch coffee shopsAddiction Biology, 2005